CAH Stock Analysis: Buy, Sell, or Hold?
CAH - Cardinal Health, Inc.
$199.77
4.57 (2.34%)
▲
5d:
+9.46%
30d:
-6.65%
90d:
-11.44%
BUY
HIGH Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CAH this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CAH trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: CAH trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$327.77
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$203.52
1.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $199.77, which is considered fair relative to its 30-day fair value range of $189.95 to $211.10. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.7) compared to its historical average (19.0). Remarkably, the market is currently pricing in an annual earnings decline of 4.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CAH is in a downtrend. The price is approaching resistance at $201.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CAH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $245.27 (+22.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CAH is in a downtrend. The price is approaching resistance at $201.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CAH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $245.27 (+22.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$189.95 -
$211.10
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.8% below Wall St target ($245.27)
Trading Range Analysis
30-Day Trading Range
$189.95 -
$211.10
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$180.45
Resistance Level
$201.80
Current Trend
Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.68
Wall Street Target
$245.27
(+22.8%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-19.5%
Profit Margin
0.6%
Valuation Discount vs History
-4.3% cheaper
PE vs Historical
16.7 vs 19.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.3%
(market-implied from PE analysis)
1-Year Target
$191.18
(-4%)
2-Year Target
$182.96
(-8%)
3-Year Target
$175.09
(-12%)
3-Yr Target (if PE normalizes)
(PE: 17→19)
$199.46
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 11.2%)
$364.24
(+82%)
Base:
(SPY PE: 16.7, Growth: 11.2%)
$274.89
(+38%)
Bear:
(PE: 14.2, Growth: 11.2%)
$233.66
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 29.76 | Current EPS (TTM): $6.56
Bull Case
$392.04
(+96%)
Analyst growth 82.6%, PE expands to 32.7
Base Case
$356.40
(+78%)
Market implied 82.6%, PE stable at 29.8
Bear Case
$132.74
(-34%)
Severe decline -20.0%, PE contracts to 25.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.7 to 19.0
Stabilization Target:
$227.57
(+13.9%)
PE Expansion Potential:
+13.9%
Share & Embed Analysis
Last updated: May 19, 2026 1:42 AM ET
Data refreshes hourly during market hours. Next update: 2:42 AM
Data refreshes hourly during market hours. Next update: 2:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-05
Ro Khanna
SELL
2026-01-23
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$950 | 57 HOLD |
|
COR
Cencora Inc. |
BUY
17 analysts |
$357 | 53 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$87 | 56 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
